Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Elizabeth Fox,

Elizabeth Fox

faculty photo
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
The Children's Hospital of Philadelphia
Division of Oncology
CTRB4016
3501 Civic Center Blvd
Philadelphia, PA 19104
Education:
BS (Laboratory Sciences)
Northeastern University, College of Pharmacy & Allied Health, Boston, MA, 1988.
MD
Pennsylvania State University College of Medicine Hershey, PA, 1993.
MS (Clinical Research)
Duke University College of Medicine Durham, NC, 2006.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Selected Publications

55. Lodish MB, Gkourogianni A, Bornstein E, Sinaii N, Fox E, Chuk M, Marcus L, Akshintala S, Balis F, Widemann B, and Stratakis CA: Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapy. Int J Pediatric Endocrinol Feb 2015.

Jenssen B, Lautz A, Yum S, Waanders A, Fox E: A 6-year old with Leg Cramps Pediatrics 2015.

Akshintala S, Dombi E, Glod J, Fox E, Lodish M, Whitcomb P, Balis FM, Widemann BC: Response and Resistance to the Receptor Tyrosine Kinase Inhibitor Vandetanib in Pediatric Patients with Medullary Thyroid Carcinoma. American Society of Pediatric Hematology Oncology; Phoenix, AZ 2015.

Norris RE, Fox E, Reid JM, zRalya AT, Lui X, Minard C, Dahl J, Eubank R, Weigel B: Phase 1 Trial of Ortuxizumab (MORAb-004) in Children with Relapsed or Refractory Solid Tumors: A Children’s Oncology Group Phase 1 Consortium Study (ADVL1213). American Society of Clinical Oncology, Chicago, IL 2015.

Cole PD, Metzger M, Drachtman RA, Horton TM, Lui X, Ahern C, Minard C, Fox E, Blaney S, Weigel B, Kelly K: A Phase 1 trial of brentuximab vedotin in combination with gemcitabine for pediatric and young adult patients with relapsed or refractory Hodgkin lymphoma, a Children’s Oncology Group report. American Society of Clinical Oncology, Chicago, IL 2015.

Lee A, Glade Bender G, Weigel B, Fox E, Huff A, Tada H, Blaney S, Langmuir P: A Phase 2 Study of Pazopanib in Children, Adolescents, and Young Adults with Refractory Solid Tumors. American Society of Clinical Oncology, Chicago, IL 2015.

Kim A, Widemann BC, Krailo M, Jayaprakash N, Fox E, Weige BJ, Blaney SM: Phase 2 trial of Sorafenib in Children and Young Adults with Refractory Solid Tumors: A Report from the Children’s Oncology Group Pediatric Blood and Cancer 2015.

Greengard E, Mosse P, Ahern C, Minard C, Blaney S, Fox E, Weigel B: A Phase 1 Study of Crizotinib in Combination with Conventional Chemotherapy for Relapsed or Refractory Solid Tumors or Analplastic Large Cell Lymphoma: A Children’s Oncology group Phase 1 Consortium Study. American Society Clinical Oncology, Chicago, IL 2015.

Fox E, Amodei K, Mattei P, Kolon T, Johnson A, Darge C, Balis FM: Longitudinal assessment of renal function using cystatin C and functional MRI in children with newly diagnosed renal tumors. Cancer and the Kidney (c-kin) International, Brussels, Belgium 2015.

Himebauch AS, Nicolson SA, Sisko M, Moorthy G, Fuller S, Gaynor JW, Zuppa A, Fox E, Kilbaugh T. : Skeletal Muscle and Plasma Concentrations of Cefazolin during Cardiac Surgery in Infants. J Thoracic Cardiovascular Surgery 148(6): 2634-41, Dec 2014.

back to top
Last updated: 06/13/2015
The Trustees of the University of Pennsylvania